ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED) (ALBIOSS-BAL)
Efficacy of Albumin Replacement and Balanced Solution in Patients with Septic Shock (the ALBIOSS-BALANCED Trial): a 2-by-2 Factorial, Investigator-initiated, Open- Label, Multicenter, Randomized, Controlled Trial
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
A PHASE3 clinical study on Septic Shock, this trial is completed. The trial is conducted by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Apr 2025 — Sep 2025 [monthly]
Completed PHASE3
Status: Unknown → Completed
-
Sep 2024 — Apr 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
May 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
May 2021 — May 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jan 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Oct 2019 — Jan 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Oct 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Istituto Di Ricerche Farmacologiche Mario Negri
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alessandria, Italy , Ancona, Italy , Bari, Italy , Bergamo, Italy , Bologna, Italy , Borgo San Lorenzo, Italy , Cinisello Balsamo, Italy , Cona, Italy , Desio, Italy , Empoli, Italy and 24 more locations